Timber Pharmaceuticals

Woodcliff Lake, United States Founded: 2011 • Age: 15 yrs Acquired By LEO Pharma
Therapeutics for dermatological rare diseases are developed.
Request Access

About Timber Pharmaceuticals

Timber Pharmaceuticals is a company based in Woodcliff Lake (United States) founded in 2011 was acquired by LEO Pharma in August 2023.. The company has 5 employees as of January 31, 2022. Timber Pharmaceuticals operates in a competitive market with competitors including Revance Therapeutics, Dermavant, Sol-Gel Technologies, SkinMedica and Hugel, among others.

  • Headquarter Woodcliff Lake, United States
  • Employees 5 as on 31 Jan, 2022
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Biopharmx Corp
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $83.18 K
    -91
    as on Dec 31, 2022
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $25 M (USD), Post-IPO

    Mar 01, 2020

  • Investors
    LEO Pharma

    & 1 more

  • Employee Count
    5

    as on Jan 31, 2022

  • Acquired by
    LEO Pharma

    (Aug 21, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Timber Pharmaceuticals
Headcount 1-10
Employee Profiles 1
Board Members and Advisors 2
Employee Profiles
People
John Koconis
CEO & Chairman

Unlock access to complete

Board Members and Advisors
people
Edward Sitar
Director
people
David Cohen
Director

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Timber Pharmaceuticals

  • Total Funding
  • Total Rounds 2
  • Last Round Post-IPO — $25.0M
  • First Round

    (15 Sep 2018)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2020 Amount Post-IPO - Timber Pharmaceuticals Valuation

investors

Sep, 2018 Amount Grant - Timber Pharmaceuticals Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Timber Pharmaceuticals

Timber Pharmaceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include LEO Pharma and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Developer of drugs for treating dermatology diseases
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Timber Pharmaceuticals

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Timber Pharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Timber Pharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Timber Pharmaceuticals

Timber Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Revance Therapeutics, Dermavant, Sol-Gel Technologies, SkinMedica and Hugel, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
domain founded_year HQ Location
Small molecule therapeutics for inflammatory skin diseases are developed.
domain founded_year HQ Location
Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis.
domain founded_year HQ Location
Skin care products are developed and manufactured by SkinMedica.
domain founded_year HQ Location
Therapeutics in aesthetics are developed, including botulinum toxin products.
domain founded_year HQ Location
Therapeutics for multiple diseases including dermatology and neurology are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Timber Pharmaceuticals

Frequently Asked Questions about Timber Pharmaceuticals

When was Timber Pharmaceuticals founded?

Timber Pharmaceuticals was founded in 2011 and raised its 1st funding round 7 years after it was founded.

Where is Timber Pharmaceuticals located?

Timber Pharmaceuticals is headquartered in Woodcliff Lake, United States. It is registered at Woodcliff Lake, New Jersey, United States.

Who is the current CEO of Timber Pharmaceuticals?

John Koconis is the current CEO of Timber Pharmaceuticals.

How many employees does Timber Pharmaceuticals have?

As of Jan 31, 2022, the latest employee count at Timber Pharmaceuticals is 5.

What is the annual revenue of Timber Pharmaceuticals?

Annual revenue of Timber Pharmaceuticals is $83.18K as on Dec 31, 2022.

What does Timber Pharmaceuticals do?

Timber Pharmaceuticalsdevelops drugs for the dermatoological rare diseases. The leading candidate PAT-001 will begin its phase 2B study for Congenital Ichthyosis as claimed by the company in 2019. Its proprietary IPEG delivery system optimizes API delivery from affected skin layers hence helps in minimizing systemic absorption and removing irritating excipients.

Who are the top competitors of Timber Pharmaceuticals?

Timber Pharmaceuticals's top competitors include Revance Therapeutics, Dermavant and Bausch Health.

Who are Timber Pharmaceuticals's investors?

Timber Pharmaceuticals has 2 investors. Key investors include LEO Pharma, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available